Table 2.
Relationships between VEGF-A expression and clinicopathological characteristics in 90 gastric adenocarcinoma cases
| Characteristics | VEGF expression (%) | p value | |
|---|---|---|---|
|
| |||
| Low | High | ||
| Total | 41 | 49 | |
| Average years | 62.8±12.3 | 61.6±12.4 | |
| <65 | 22 (53.7) | 30 (61.2) | 0.469 |
| ≥65 | 19 (46.3) | 19 (38.8) | |
| Gender | |||
| Male | 24 (58.5) | 29 (59.2) | 0.95 |
| Female | 17 (41.5) | 20 (40.8) | |
| Histologic grade | |||
| I~II | 12 (29.3) | 9(18.4) | 0.223 |
| II~III | 29 (70.7) | 40 (81.6) | |
| TNM stage | |||
| I-II | 21 (51.2) | 15 (30.6) | 0.047 |
| III-IV | 20 (48.8) | 34 (69.4) | |
| Tumor size (cm) | 4.8±1.7 | 6.5±3.1 | |
| <5 cm | 21 (51.2) | 14 (28.6) | 0.028 |
| ≥5 cm | 20 (48.8) | 35 (71.4) | |
| Lymphovascular Invasion | 6 (14.6) | 23 (46.9) | 0.001 |
| Positive lymph nodes | 24 (58.5) | 43 (87.8) | 0.002 |
| Distant metastasis | 2 (4.9) | 2 (4.1) | 0.855 |